MEMPHASYS LIMITED. overview

Sydney, Australia (ABN Newswire) - Memphasys Limited (ASX:MEM) (FRA:IG7) is pleased to announce the successful unblinding and data analysis of its pivotal clinical trial for the Felix(TM) System, confirming its best-in-class performance in sperm selection for Assisted Reproductive Technology (ART). The study was conducted in clinical partnership through Monash IVF. Key Highlights: - Clinical Trial Positive Outcome: The Felix(TM) System has successfully demonstrated a positive primary endpoint of...

Sydney, Australia (ABN Newswire) - Memphasys Limited (ASX:MEM) (FRA:IG7) is pleased to announce successful completion of the data lock for the pivotal Felix(TM) clinical trial. This marks a critical milestone in ensuring the accuracy and integrity of the trial data through rigorous data management and source data verification processes; and follows MEM's approval of the final data management and statistical analysis plans. Key Highlights: - Following final quality check and data validation, data...